cimetidine has been researched along with Porphyria Cutanea Tarda in 2 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.
Excerpt | Relevance | Reference |
---|---|---|
"The efficacy of the H2 receptor antagonist, cimetidine, in the treatment of a patient with porphyria cutanea tarda (PCT) was evaluated." | 7.69 | Cimetidine in the treatment of porphyria cutanea tarda. ( Horie, Y; Kawasaki, H; Kondo, M; Ohgi, N; Okano, J; Sassa, S; Tanaka, K; Yamamoto, S, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, Y | 1 |
Sato-Matsumura, KC | 1 |
Horie, Y | 1 |
Tanaka, K | 1 |
Okano, J | 1 |
Ohgi, N | 1 |
Kawasaki, H | 1 |
Yamamoto, S | 1 |
Kondo, M | 1 |
Sassa, S | 1 |
2 other studies available for cimetidine and Porphyria Cutanea Tarda
Article | Year |
---|---|
Effective treatment for porphyria cutanea tarda with oral cimetidine.
Topics: 5-Aminolevulinate Synthetase; Aged; Anti-Ulcer Agents; Cimetidine; Coproporphyrins; Enzyme Inhibitor | 2010 |
Cimetidine in the treatment of porphyria cutanea tarda.
Topics: Cimetidine; Histamine H2 Antagonists; Humans; Male; Middle Aged; Porphyria Cutanea Tarda; Porphyrins | 1996 |